0001183740-19-000030.txt : 20190225
0001183740-19-000030.hdr.sgml : 20190225
20190225170451
ACCESSION NUMBER: 0001183740-19-000030
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06c
FILED AS OF DATE: 20190225
DATE AS OF CHANGE: 20190225
EFFECTIVENESS DATE: 20190225
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PharmaCielo Holdings Ltd.
CENTRAL INDEX KEY: 0001641777
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-316289
FILM NUMBER: 19630353
BUSINESS ADDRESS:
STREET 1: 82 RICHMOND STREET EAST, SUITE 200
CITY: TORONTO
STATE: A6
ZIP: M5C 1P1
BUSINESS PHONE: 6475604640
MAIL ADDRESS:
STREET 1: 82 RICHMOND STREET EAST, SUITE 200
CITY: TORONTO
STATE: A6
ZIP: M5C 1P1
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaCielo Ltd.
DATE OF NAME CHANGE: 20150507
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001641777
PharmaCielo Holdings Ltd.
82 RICHMOND STREET EAST, SUITE 200
TORONTO
A6
ONTARIO, CANADA
M5C 1P1
6475604640
CANADA (FEDERAL LEVEL)
PharmaCielo Ltd.
Corporation
true
2014
Scott
Laitinen
82 Richmond Street East, Suite 200
Toronto
A6
ONTARIO, CANADA
M5C 1P1
Executive Officer
Henning
von Koss
82 Richmond Street East, Suite 200
Toronto
A6
ONTARIO, CANADA
M5C 1P1
Director
Carlos
Uribe
82 Richmond Street East, Suite 200
Toronto
A6
ONTARIO, CANADA
M5C 1P1
Director
Delon
Human
82 Richmond Street East, Suite 200
Toronto
A6
ONTARIO, CANADA
M5C 1P1
Director
David
Attard
82 Richmond Street East, Suite 200
Toronto
A6
ONTARIO, CANADA
M5C 1P1
Executive Officer
Director
Federico
Cock-Correa
82 Richmond Street East, Suite 200
Toronto
A6
ONTARIO, CANADA
M5C 1P1
Director
David
Gordon
82 Richmond Street East, Suite 200
Toronto
A6
ONTARIO, CANADA
M5C 1P1
Executive Officer
Matteo
Pellegrini
82 Richmond Street East, Suite 200
Toronto
A6
ONTARIO, CANADA
M5C 1P1
Director
Simon
Langelier
82 Richmond Street East, Suite 200
Toronto
A6
ONTARIO, CANADA
M5C 1P1
Director
Douglas
Bache
82 Richmond Street East, Suite 200
Toronto
A6
ONTARIO, CANADA
M5C 1P1
Director
Pharmaceuticals
Decline to Disclose
- 06c
true
0001183740-18-000126
2018-06-25
false
true
true
true
true
2,504,746 Subscription Receipts at C$3.35 per Subscription Receipt, convertible into shares upon satisfaction of escrow release conditions at or before September 30, 2018.
true
In connection with the acquisition of all the issued and outstanding shares of the Issuer by AAJ Capital 1 Corp. ("AAJ") by way of a three-cornered merger pursuant to a merger agreement between the Issuer, AAJ and a wholly-owned subsidiary of AAJ.
17627
6315156
6315156
0
2,504,746 Subscription Receipts were sold at C$3.35 per Subscription Receipt (US$2.52 per Subscription Receipt, based on exchange rate of US$1:C$1.3303 on 6/25/2018; US$2.56 per Subscription Receipt, based on exchange rate of US$1:C$1.3088 on 7/25/2018).
false
107
0
0
0
false
PharmaCielo Holdings Ltd.
/s/ Scott Laitinen
Scott Laitinen
Chief Financial Officer
2019-02-11